Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Use of DPP-4 Inhibitors
Baptist Gallwitz
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 292

Showing 1-25 of 292 citing articles:

Type II diabetes mellitus: a review on recent drug based therapeutics
Santwana Padhi, Amit Kumar Nayak, Anindita Behera
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110708-110708
Open Access | Times Cited: 511
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili, Michael Roden
Molecular Metabolism (2020) Vol. 50, pp. 101122-101122
Open Access | Times Cited: 239
COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
Margaret F. Bassendine, Simon H. Bridge, Geoffrey W. McCaughan, et al.
Journal of Diabetes (2020) Vol. 12, Iss. 9, pp. 649-658
Open Access | Times Cited: 145
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1069-1083
Open Access | Times Cited: 143
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 109
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, et al.
Metabolism (2022) Vol. 137, pp. 155332-155332
Closed Access | Times Cited: 95
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations
David M. Williams, Hannah Jones, Jeffrey W. Stephens
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 281-295
Open Access | Times Cited: 76
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature
Kunika Saini, Smriti Sharma, Yousuf Aziz Khan
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 65
Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review
Rodrigo Haber Mellen, Otávio Simões Girotto, Eduarda Boni Marques, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 136-136
Open Access | Times Cited: 45
Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
Andreas Ritter, Nina‐Naomi Kreis, Frank Louwen, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5793-5793
Open Access | Times Cited: 128
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
Bing Bai, Alexandr Belovodskiy, Mostofa Abu Hena, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2905-2925
Closed Access | Times Cited: 93
New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway
Sheng‐Kai Hsu, Kai‐Chun Cheng, Miracle Oluebube Mgbeahuruike, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9453-9453
Open Access | Times Cited: 58
Adherence and persistence rates of major antidiabetic medications: a review
David Seung U Lee, Howard Lee
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Linyu Wu, Xiao‐Hui Xian, Guangyu Xu, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 45
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
Baptist Gallwitz
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 44
Computer-Aided Screening of Phytoconstituents from Ocimum tenuiflorum against Diabetes Mellitus Targeting DPP4 Inhibition: A Combination of Molecular Docking, Molecular Dynamics, and Pharmacokinetics Approaches
Harshit Sajal, Shashank M. Patil, Ranjith Raj, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5133-5133
Open Access | Times Cited: 40
2-Phenethylamines in Medicinal Chemistry: A Review
Carlos T. Nieto, Alejandro Manchado, Leland Belda, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 855-855
Open Access | Times Cited: 33
A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications
Fatma Haddad, Ghadeer Dokmak, Maryam Bader, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 33
Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
Eugenia Piragine, Davide Petri, Alma Martelli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1981-1981
Open Access | Times Cited: 28
The Role of Adiponectin during Pregnancy and Gestational Diabetes
Brittany Gruber, Vernon W. Dolinsky
Life (2023) Vol. 13, Iss. 2, pp. 301-301
Open Access | Times Cited: 25
Proline Analogues
Vladimir Kubyshkin, Marina Rubini
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8130-8232
Closed Access | Times Cited: 10
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment
Ewa Radzioch, Bartłomiej Dąbek, Marta Balcerczyk-Lis, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 765-765
Open Access | Times Cited: 8
The role of avocado plant and its derivatives in the management of diabetes mellitus: a natural approach to glycemic control
Mary Olaoluwa Agunloye, Daniel Udofia Owu, Olufunke Onaadepo, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access | Times Cited: 1
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, et al.
Comprehensive physiology (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top